("GenIP" or the "Company")
The collaboration will embed GenIP's Invention Evaluator reports into 360's innovation platform, making it the standardised first step in their venture-building methodology. This will ensure every 360's project undergoes a rigorous assessment for market potential and commercial readiness before moving forward.
Through this partnership GenIP's role transforms from being an external service provider into becoming a core component of 360's platform, securing a predictable, recurring revenue stream. It also gives GenIP direct access to a pipeline of 50+ active engagements and new ventures, and over 100 corporate clients, expanding its market presence beyond its traditional academic base.
The partnership also creates significant cross-selling opportunities for GenIP's recruitment and leadership hiring services as 360's portfolio companies scale and build their teams.
"This corporate strategic partnership represents a significant milestone for GenIP. By embedding our Invention Evaluator into 360's global framework, we transition from being a project-based service to a foundational part of their innovation infrastructure. This provides GenIP with predictable revenue and direct access to a broad corporate pipeline, reinforcing our strategy to grow our presence in the corporate sector."
"Integration of GenIP's services addresses two critical gaps we see in early-stage innovation: rigorous validation and strategic talent acquisition. Their Invention Evaluator ensures we are not just advancing interesting ideas, but viable ones with clear paths to market. Further, their talent platform helps ventures build teams that bring both expertise and lived experience. For our global network of clients and partners, this means better investment decisions and stronger ventures. For the communities we serve, it means innovations that actually work for them."
About 360 Social Impact Studios
360
● Innovation Program Design - ISO 56002-aligned frameworks guiding institutions from ideation to implementation.
●
● Leadership Transformation - equipping organisations with the mindset and culture to embed innovation at scale.
Recent work includes AI-enabled diagnostics, next-generation rehabilitation platforms, and licensing systems-areas where robust IP and market assessments are critical for investor confidence.
For further information regarding GenIP, please visit www.genip.ai, or contact:
|
|
|
Via |
|
|
|
|
|
|
|
Tel: +44 (0)20 7399 9425
|
|
|
|
|
About Reach announcements
This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.
Notes to Editors
About GenIP
GenIP provides generative artificial intelligence (GenAI) analytic services to help companies, research institutions and venture funds assess and commercialise new discoveries. GenIP combines expert human technical review with GenAI algorithms to provide insightful and verified services.
GenIP provides two complementary services:
1. Invention Evaluator: Provides bespoke research reports that assess the market potential of new technological innovations and discoveries using AI-driven proprietary software; and
2. Vortechs: which is an executive recruitment service that uses advanced machine learning algorithms and natural language processing technologies to assist in matching technology organisations with experienced executives skilled in technology commercialisation.
The Company believes that its integrated GenAI service offerings will help organisations to evaluate and commercialise their technological innovations.
Company Strategy
GenIP's goal is to be a leading Generative AI analytic services company. To achieve this, the Company has established three strategic pillars:
● Organically grow Invention Evaluator and Vortechs' revenue through institutional and corporate connections as well as increase client pipeline through marketing, advertising and social media spend.
● Expand the Generative AI service offerings within Invention Evaluator and Vortechs' to reach new customers and improve margins.
● Bolt-on acquisitions of additional Generative AI services that are helpful to our clients and have demonstrated initial market traction.
Forward looking statements
Certain statements contained in this announcement constitute forward-looking statements. When used in this announcement, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "seek", "propose", "estimate", "expect", and similar expressions, as they relate to the Company, are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding intentions, beliefs or current expectations concerning, among other things, the Company's results of operations, financial position, liquidity, prospects, growth, strategies and expectations of the industry in which the Company operates.
Such statements reflect the Company's current views with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to materially differ from those described in this announcement Should one or more of these risks or uncertainties materialise, or should assumptions underlying forward-looking statements prove incorrect, actual results may differ materially from those described in this announcement as "intended", "planned", "anticipated", "believed", "proposed", "estimated" or "expected".
For the avoidance of doubt, the contents of the Company's website and any hyperlinks accessible from the Company's website are not incorporated by reference into, and do not form part of, this announcement and investors should not rely on them.
-ENDS-
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the